全文获取类型
收费全文 | 9174篇 |
免费 | 683篇 |
国内免费 | 146篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 126篇 |
妇产科学 | 68篇 |
基础医学 | 611篇 |
口腔科学 | 58篇 |
临床医学 | 1050篇 |
内科学 | 2958篇 |
皮肤病学 | 41篇 |
神经病学 | 297篇 |
特种医学 | 725篇 |
外科学 | 569篇 |
综合类 | 713篇 |
预防医学 | 1232篇 |
眼科学 | 43篇 |
药学 | 736篇 |
2篇 | |
中国医学 | 393篇 |
肿瘤学 | 366篇 |
出版年
2024年 | 9篇 |
2023年 | 270篇 |
2022年 | 424篇 |
2021年 | 578篇 |
2020年 | 563篇 |
2019年 | 660篇 |
2018年 | 569篇 |
2017年 | 321篇 |
2016年 | 259篇 |
2015年 | 293篇 |
2014年 | 664篇 |
2013年 | 581篇 |
2012年 | 418篇 |
2011年 | 499篇 |
2010年 | 333篇 |
2009年 | 353篇 |
2008年 | 395篇 |
2007年 | 429篇 |
2006年 | 276篇 |
2005年 | 252篇 |
2004年 | 184篇 |
2003年 | 163篇 |
2002年 | 105篇 |
2001年 | 124篇 |
2000年 | 107篇 |
1999年 | 99篇 |
1998年 | 115篇 |
1997年 | 105篇 |
1996年 | 73篇 |
1995年 | 83篇 |
1994年 | 85篇 |
1993年 | 54篇 |
1992年 | 61篇 |
1991年 | 51篇 |
1990年 | 52篇 |
1989年 | 36篇 |
1988年 | 38篇 |
1987年 | 48篇 |
1986年 | 35篇 |
1985年 | 42篇 |
1984年 | 42篇 |
1983年 | 25篇 |
1982年 | 29篇 |
1981年 | 23篇 |
1980年 | 16篇 |
1979年 | 14篇 |
1977年 | 9篇 |
1976年 | 11篇 |
1975年 | 8篇 |
1974年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 28 毫秒
1.
《Cancer radiothérapie》2022,26(4):611-615
In order to provide more convenient irradiation regimens for patient comfort, radiation facility organization and health expenses, new hypofractionated protocols have been evaluated. Moderately (dose/fraction: 2.3 to 3 Gy), then ultra (dose/fraction: 5.2 to 6.1 Gy) hypofractionated irradiations were first validated. The current question is: is it possible to go forward using extreme hypofractionated regimens (EHR) based on 1 to 3 fractions. Different irradiation techniques are under investigation. However, brachytherapy remains the smartest way to deliver a high dose in a small volume. We report prospective and retrospective study results which evaluated EHR for breast and prostate brachytherapy. While oncological outcome and toxicity profile appear extremely encouraging for low-risk breast cancer after a 1 to 4 fractions (6.25 to 20 Gy/fraction), the use of a single fraction of 19 to 23 Gy appears debatable for prostate cancer. Brachytherapy represents an emblematic example of EHR but longer follow-up and more mature results are awaited in order to specify the right indications and refine the EQD2 calculation method including new biological and technical factors. 相似文献
2.
《Pancreatology》2022,22(8):1175-1180
BackgroundHepatic steatosis has been described as a common finding in adults following total pancreatectomy with islet autotransplantation (TPIAT) but it is unknown if this occurs in children and adolescents.ObjectivesTo define the frequency of post-TPIAT hepatic steatosis in a sample of children and adolescents and to identify clinical predictors of incident steatosis post-TPIAT.MethodsIn this prospective study, consecutive participants at least 1-month post-TPIAT underwent a liver MRI with proton density fat fraction (PDFF) and blood draw at our pediatric academic medical center between April 2021 and January 2022. Comparison clinical pre-TPIAT liver MRI or ultrasound and insulin use and graft function data were extracted from the medical record. T-tests were used for the comparison of means across continuous variables between participants with and without post-TPIAT steatosis.ResultsA total of 20 participants (mean: 13 ± 4 years; 12 female) were evaluated. Mean liver PDFF at research MRI was 7.4 ± 6.2% (range: 2–25%). Seven participants (35%) had categorical hepatic steatosis (PDFF>5%) post-TPIAT, five of whom had pre-TPIAT steatosis, reflecting a 13% (2/15; 95% CI: 2–40%) incidence of post-TPIAT steatosis. Participant characteristics were not significantly different between subgroups with and without post-TPIAT steatosis. Mean PDFF at research MRI was not different between graft function subgroups (7.5% optimal/good vs. 7.3% marginal/failure; p = .96).ConclusionOur study shows a moderate prevalence but low incidence of hepatic steatosis in a small sample of children and adolescents post-TPIAT. This study raises questions about a causal relationship between TPIAT and hepatic steatosis. 相似文献
3.
4.
5.
6.
7.
8.
9.
目的:系统评价丹红注射液对急性心肌梗死(AMI)经皮冠状动脉介入治疗(PCI)围手术期心功能和心肌梗塞溶栓治疗(TIMI)血流分级的影响。方法:计算机检索CNKI,万方数据库,维普数据库,Pub Med,CBM,Web of Science,The Cochrane Library共7个数据库,全面采集在PCI围手术期应用丹红注射液治疗急性心梗的临床试验,采用Cochrane风险评价表进行文献质量评价,运用Revman 5.3软件进行Meta分析。结果:共纳入12个临床试验,包含1131例患者,其中丹红治疗组569例,对照组562例,结果显示在常规治疗的基础上加入丹红注射液治疗,患者的左室射血分数明显增高[均数差(MD)=6.62,95%可信区间(CI)(4.91,8.34),P<0.00001],TIMI分级3级患者明显增多[相对危险度(RR)=0.22,95%CI(0.12,0.41),P<0.00001],脑利钠肽水平明显降低[MD=-151.86,95%CI(-247.00,-56.72),P=0.002]。结论:丹红注射液可以提高急性心梗PCI围手术期心功能和增加TIMI血流的分级。 相似文献